Elevai Labs Inc. announced on December 4, 2024, that its wholly-owned subsidiary, Elevai Skincare Inc., achieved a record-breaking sales month in 2024. This milestone positions the skincare division with strong momentum heading into the holiday season.
The company attributes this achievement partly to strategic restructuring efforts, which are contributing to the record monthly sales. This performance sets the stage for positive projections for year-end growth within the skincare segment.
Elevai Skincare specializes in physician-dispensed skin and hair care applications, leveraging novel proprietary science-backed technologies, including its stem cell exosome technology. The record sales highlight the division's market acceptance and operational efficiency.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.